Founded in 2000, Sectoral Asset Management Inc. is an industry-leading specialist in managing global investment portfolios in the healthcare sector.

Mission: 
Sectoral Asset Management is exclusively focused on managing global healthcare portfolios. Our objective is to achieve superior returns for our investors by concentrating on primary research.

We strive to provide unparalleled service to our investors.
We actively champion and maintain the highest educational and quality standards.

Our firm is 100% employees owned.

Sectoral's investment philosophy is based on fundamental research in the healthcare sector. This means that our investment team must have multiple areas of expertise. Sectoral's investment professionals have managed healthcare/biotechnology portfolios for over twelve years. All members of our team are CFA charterholders or candidates and most have earned postgraduate degrees in both business and science.

Sectoral Asset Management focuses on four main portfolio strategies:
Biotech
Healthcare
Emerging Markets
Small & Mid-Cap Healthcare 






Intellia Therapeutics

Mineralys Therapeutics

Better Therapeutics

Advaxis

Amolyt Pharma

Apellis Pharmaceuticals

Aprea

Babylon

Cogent Biosciences

Viracta Therapeutics

RainDance Technologies

Checkmate Pharmaceuticals

REGENXBIO

Shockwave Medical

Sectoral Asset Management

Sectoral Asset Management est heureux d’avoir contribué à la première conférence de la série Les Grands de l'industrie par MEDTEQ+ permettant aux entrepreneurs de côtoyer les grands joueurs de l'industrie des technologies en santé. 
 
Nous avons eu le privilège d'accueillir Betsabeh MadaniHermann, graduée de The University of British Columbia et anciennement se Mitacs, mais maintenant cheffe de la recherche mondiale pour Philips.
 
Merci à tous ceux qui ont collaboré à l'organisation de l'événement! Maxime Ranger, Josée Laflamme, Annie-Kim Gilbert, ROBIC, Espace CDPQ. 
 
----------------------------------------------------------------------------------
 
Sectoral Asset Management is pleased to have contributed to the first event of the Industry Leaders conference series by MEDTEQ+, bringing entrepreneurs face-to-face with key individuals in the medtech industry. 

We had the privilege of hosting Betsabeh MadaniHermann, The University of British Columbia graduate and formerly of Mitacs, now Head of Global Research for Philips.

Thanks to all that were instrumental in organising this first conference! Maxime Ranger, Josée Laflamme, Annie-Kim Gilbert, ROBIC, Espace CDPQ. 

The firm hosted another successful edition of its Healthcare Study Trip, the 21st, and had the great honour of having the Honourable Pierre Fitzgibbon, Minister of Economy, Innovation and Energy announce the first close of its new Fonds Medtech Ventures, with initial committed capital of CAD 41.5m. We are proud to partner with the Government of Quebec and Investissement Québec as well as Fonds de solidarité FTQ and private investors in this new endeavour. We continue to work towards a target fund size of CAD 100m and are excited to begin our work with promising medical technology companies in Quebec and the rest of the country.

We are honored to receive the 2023 Refinitiv Lipper Award for the Sectoral Healthcare Opportunities Fund, as Best Fund over 3 Years in the UK, Equity Sector Healthcare category.
Our heartfelt congratulations to Marco Cianflone, CFA, Senior Portfolio Manager, and the Investment Team.
This recognition awards the long-term investment approach and the teamwork of Sectoral Asset Management Investment Professionals. #healthcare

We are honored to receive the 2023 Refinitiv Lipper Award for the Sectoral Healthcare Opportunities Fund, as Best Fund over 3 Years in Austria, Equity Sector Healthcare category.
Our heartfelt congratulations to Marco Cianflone, CFA, Senior Portfolio Manager, and the Investment Team.
This recognition awards the long-term investment approach and the teamwork of Sectoral Asset Management Investment Professionals. #healthcare

Domain Not Resolving

Cloudflare Hosting

CrUX Dataset

Cloudflare JS

CDN JS

CrUX Top 50m

dotdigital Engagement Cloud

Partner & COO

Marc-Andre Marcotte, CFA

Chief Investment Officer

Michael Sjöström

Principal

Gabriel Douville

Sales and Support

Yingdong Zhang

Manager, Information Technology

Alex Bernal

Antoine BLONDIN

Portfolio Manager, Sectoral Healthcare Opportunities Fund

Marco Cianflone

Banking and Wealth Management

Alain J. Gilbert

Network Administrator

Basil Pitt

Senior Associate, Private Investments

Catherine Poulin-Filion

Laurent Chaix

Oern Stuge

Winnie Pao

Marilina Mastronardi

Brett Goodin

Vihang Errunza

Stephen Marshall

IT Manager

Stefan Mathias Larson

Partner

Guillaume Aquin

Senior Manager Trading & Operations

Nandita Das

Accounting Manager

Paulina Niewiadomska

Portfolio Manager

Dimo Vodenitcharov

Michael Sjostrom

Co-Founder

Justin Gelinas

Operations Manager

Viracta Therapeutics is a precision oncology company focused on new treatment of virus-associated malignancies.

Boundless Bio is a precision oncology company that develops therapeutics directed against extrachromosomal DNA in aggressive cancers.

Turnstone Biologics is a privately-held clinical stage biotech company.

LENZ Therapeutics operates as an organization engaged in the late-stage clinical development of pharmaceuticals for the eyes.

Mineralys Therapeutics is a clinical-stage biopharmaceutical company committed to developing therapy for the treatment of hypertension.

Intellia Therapeutics is a genome editing company that develops curative gene-editing treatments.

Better Therapeutics develops prescription software for treating cardiometabolic diseases.

Amolyt Pharma specializes in peptides for the treatment of rare endocrine and metabolic disorders.

Phagenesis is engaged in the development of a device to treat dysphagia, a condition that disables the safe swallowing of food.

Effector Therapeutics is an early-stage company focused on the discovery and development of small molecule cancer therapeutics.

Investors Active in Switzerland

Post IPO Investors with Investments in Greater Boston Area

Private Montréal Companies

Private Equity Firms with Investments in California

Sectoral Asset Management Inc. is an industry-leading specialist in managing global investment portfolios in the healthcare sector.

Sectoral maintains offices in Montreal and Geneva and is a proud member of the State Street Global Alliance. They currently manage approximately US $4.0 billion in assets.

Sectoral Emerging Markets Healthcare Fund, L.P.

S.A.M. HEALTHCARE/BIOTECH EQUITY FUND I LP

Montréal

Quebec

Canada

North America

Phagenesis Closes $42M Series D Financing

EQT Life Sciences and Sectoral lead $42M investment in medtech Phagenesis

Phagenesis, a medical device company specializing in the treatment of swallowing disorders, successfully ...

The Week’s 10 Biggest Funding Rounds: Quantinuum And Flexport Lock Up Huge Rounds

France

Europe

United Kingdom

Hong Kong

Asia

India

Austria

HTML5

Google Analytics

jQuery

Google Fonts

Comodo PositiveSSL Certificates

Apache Server

Google Tag Manager

Bootstrap

Google Maps API

Vimeo

GLC Asset Management Group Ltd is a competitor of Sectoral Asset Management Inc. specializing in thematic investing. The company focuses on identifying long-term trends and investing in companies positioned to benefit from these trends.

GLC Asset Management Group Ltd

Auspice & Beringer Capital is a competitor of Sectoral Asset Management Inc. specializing in thematic investing. The company focuses on identifying long-term trends and investing in companies positioned to benefit from these trends.

Auspice & Beringer Capital

Asteria Investment Managers is a competitor of Sectoral Asset Management Inc. specializing in thematic investing. The company focuses on identifying long-term trends and investing in companies positioned to benefit from these trends.

Asteria Investment Managers

BlueMark is a competitor of Sectoral Asset Management Inc. specializing in thematic investing. The company focuses on identifying long-term trends and investing in companies positioned to benefit from these trends.

BlueMark

GreenGrowth is a competitor of Sectoral Asset Management Inc. specializing in thematic investing. The company focuses on identifying long-term trends and investing in companies positioned to benefit from these trends.

GreenGrowth

Sectoral Asset Management Inc. is a leading investment management firm specializing in global thematic investing. The company focuses on identifying long-term trends and investing in companies that are well-positioned to benefit from these trends. With a research-driven approach, Sectoral aims to deliver superior risk-adjusted returns for its clients.

news impact assignment basic	general
public peers	general	May 12, 2024 12:01 AM	5c3fc21d
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general	May 12, 2024 5:40 AM	3254d841
company summary	general
signals	general
crunchbase trigger	general	Nov 25, 2024 9:09 AM	ec691e76
crunchbase profile	general	Nov 25, 2024 11:38 AM	ea0f74a4
li profile	general	May 12, 2024 12:01 AM	61c3a189
translate crunchbase fundingrounds	general	Nov 25, 2024 2:08 PM	a3b136cf
peers	general
news basic	general	May 12, 2024 12:01 AM	da5e9636
bundesanzeiger	filings
financials download nd	financials
private financials	financials

COM:SECTORAL

Sectoral Asset Management Inc.